Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.87 Analyst target: $6.00 Upside: 587.36%
Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States. The company is headquartered in Woburn, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.